EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

A new treatment for focal dystonias: incobotulinumtoxinA (Xeomin®), a botulinum neurotoxin type A free from complexing proteins

Joohi Jimenez-Shahed

Neuropsychiatric Disease and Treatment · 2011-12 · 13

DOI: 10.2147/ndt.s16085 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuropsychiatric Disease and Treatment, 2011-12. Verfasst von Joohi Jimenez-Shahed. Beteiligte Einrichtung: Department of Neurology, Baylor College of Medicine, Houston, TX, USA. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

blepharospasmbotulinum toxincervical dystoniacomplexing proteinsdystoniaincobotulinumtoxinA (Xeomin®)

Autor:innen und Institutionen

  • Department of Neurology, Baylor College of Medicine, Houston, TX, USA.

Zitieren

APA

Jimenez-Shahed, J. (2011). A new treatment for focal dystonias: incobotulinumtoxinA (Xeomin®), a botulinum neurotoxin type A free from complexing proteins. Neuropsychiatric Disease and Treatment, 13. https://doi.org/10.2147/ndt.s16085

Vancouver

Jimenez-Shahed J. A new treatment for focal dystonias: incobotulinumtoxinA (Xeomin®), a botulinum neurotoxin type A free from complexing proteins. Neuropsychiatric Disease and Treatment. 2011:13. doi:10.2147/ndt.s16085

BibTeX
@article{JimenezShahed2011,
  author = {Jimenez-Shahed, Joohi},
  title = {A new treatment for focal dystonias: incobotulinumtoxinA (Xeomin®), a botulinum neurotoxin type A free from complexing proteins},
  journal = {Neuropsychiatric Disease and Treatment},
  year = {2011},
  pages = {13},
  doi = {10.2147/ndt.s16085}
}
Kostenlos starten →